National Conference

Save the Date

 

Friday-Saturday, September 11-12  •  Attend or Livestream

Loews Chicago O’Hare Hotel  •  5300 N. River Road, Rosemont, IL 60018

Registration opens spring 2020. Sign up and be the first to get registration alerts. 

About the Conference

The ABTA National Conference is the only advocacy-led brain tumor meeting that brings together patients, caregivers, researchers and the medical community to learn the latest information in brain tumor research, treatment and care.

In addition to providing the latest research and treatment updates, the conference program includes separate breakout sessions for patients and caregivers to exchange experiences, learn coping methods and build a support network.

2020 Co-Chairs

Jean Arzbaecher, APRN, MS, CNRN
Advanced Practice Nurse
The University of Illinois at Chicago 

Mark R. Gilbert, MD
Chief & Senior Investigator, CCR Deputy Director, Neuro-Oncology Branch Center for Cancer Research National Cancer Institute, National Institutes of Health

National Conference Sponsors

Funded in part by Genentech.

 


 

Have Questions?

Contact us at info@abta.org or call 800-886-ABTA (2282).


National Conference

2019 Conference

Close Menu
en English
X

Mindee Plugues

Member

Mindee J. Plugues, of Los Angeles, CA, is vice president, marketing for the Applebee’s brand and brings skills including brand strategy, executive leadership, and marketing to the board. Plugues has been an ABTA donor since April 2001, following her father’s passing from GBM. She is also a former member of the ABTA endurance program, Team Breakthrough.

Bob Kruchten

Member

Bob Kruchten, of Mount Prospect, IL, is a sales manager at Extreme Reach, a leading advertising technology company. He has strong skills in communications and fundraising, and has been advocating for the ABTA for 19 years in tribute to his best friend, Paul Fabbri, who lost his 10-year battle with GBM in 1998. Kruchten accepted the ABTA’s Joel A. Gingras Jr. Award in 2015 on behalf of the Paul Fabbri Memorial Fund.